Welcome to Progress in Neurology and Psychiatry’s dedicated website. Progress is for health professionals in secondary and primary care looking after patients with neurological and psychiatric diseases. If you are a health professional working in the field of neurology or psychiatry you can register with us for free access to our content.Sign up for e-alerts and print copies

Latest News

Utilisation of antipsychotics

An analysis of medical database records in the UK, Italy, Spain and the United States involving a total of 1.4 million patients with schizophrenic disorder and...Read more

Online intervention for depression in people with epilepsy

Anxiety and depression are highly prevalent among people with epilepsy. Many do not have access to a professional who can offer cognitive therapy, say...Read more

Depression and overweight/obesity

Two studies in people who are overweight or obese have sought to determine the impact of psychological and/or pharmacological interventions on symptoms of...Read more

Long term benefit in myasthenia gravis

Treatment of anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis with the anti-complement monoclonal antibody eculizumab is...Read more

Guidance on rescheduling gabapentin and pregabalin

NHS England has published guidance on managing the rescheduling of gabapentin and pregabalin as Schedule 3 Controlled Drugs...Read more

More join the Dementia Consortium

More pharmaceutical companies have announced they will be part of the joint industry-charity drug discovery collaboration, the Dementia Consortium...Read more

Cannabinoids to be tested in people with Alzheimer’s disease

The charity Alzheimer Research UK is to invest £300,000 in a clinical trial to evaluate the effect of the cannabinoids spray preparation Sativex as a...Read more

Featured Articles

Diagnostic overshadowing in learning disability: think beyond the disability
Diagnostic overshadowing is increasingly recognised as contributing to health inequalities experienced by the learning disability population. This case is that of a 54-year-old male with mild-to-moderate learning disability who displayed abnormally aggressive behaviours and self-neglect. He had multiple transfers between the psychiatric and medical units during an inpatient episode, partly due to his physical health symptoms being misattributed to learning disability and challenging behaviour.
Click here to view

Factitious disorder: a case report and literature review of treatment
Diagnosis of factitious disorder (FD) is frequently difficult and patients may present with physical symptoms only, psychiatric symptoms only or with a combination of both. As long as the nature of the disease is so secretive and large-scale studies are almost impossible, every case report is important. Here, the authors present a case of severe FD and the therapeutic approach taken.
Click here to view

Management of the renal adverse effects of lithium: an audit cycle
Lithium is a standard first-line treatment for bipolar disorder and one of the recommended augmenting agents for treatment-resistant depression. However, concerns remain about the long-term organ toxicity of this drug, mainly renal adverse effects. Here, Dr Gupta and colleagues discuss their local audit of administering lithium in CKD patients and how the results were used to inform trust policy and improve clinical practice.
Click here to view

Web design and marketing agency Leamington Spa